Wednesday, February 27, 2013- Big Pharma's Blockbuster Battleat Motley Fool (Wed, Feb 27)
- Autism Shares Genetic Features With Psychiatric Disordersat Bloomberg (Wed, Feb 27)
- UPDATE 1-Mylan to buy injectable drugs unit of India's Strides for $1.6 blnat Reuters (Wed, Feb 27)
- Mylan to buy Agila of India for $1.6 billionAP (Wed, Feb 27)
- Can Optimer Optimize Shareholder Returns?at Motley Fool (Wed, Feb 27)
- Pfizer Inc (PFE): Today's Featured Drugs Winnerat TheStreet (Wed, Feb 27)
- Top Picks From Billionaire Jim Simons' Renaissance Technologiesat Seeking Alpha (Wed, Feb 27)
- Optimer Consider Strategic Alternatives as CEO Steps Downat Bloomberg (Wed, Feb 27)
- Venaxis: Appendicitis Screening Just Became Cheaperat Seeking Alpha (Wed, Feb 27)
- Expanded Approval Isn't a Sure Thingat Motley Fool (Wed, Feb 27)
- Label Expansion for Bayer's StivargaZacks (Wed, Feb 27)
- 1 Big Pharma in Survival Modeat Motley Fool (Wed, Feb 27)
- Why Investors Should Love Celgene's Apremilastat Motley Fool (Wed, Feb 27)
- Sequestration And The Enormous Implications For The U.S. Economyat Seeking Alpha (Wed, Feb 27)
- Optimer board to review strategic alternativesAP (Wed, Feb 27)
- This Is, Without Question, Pharma's Most Perilous Pipelineat Motley Fool (Wed, Feb 27)
- Glaxo’s, Pfizer’s ViiV Licenses HIV Drug for Kids to Patent Poolat Bloomberg (Wed, Feb 27)
Tuesday, February 26, 2013Add PFE News to My Yahoo!   | |
|
0.07(0.24%) May 24, 4:00PM EDT|After Hours
:
29.02